Deerfield Management Company »

Parabilis Medicines shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $52M 1.9M 27.37

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Brookdale Sr Living Note 3.500%10/1 (Principal)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Viatris (VTRS)
Centene Corporation (CNC)
Revolution Medicines Note 0.500% 5/0 (Principal)
United Therapeutics Corporation (UTHR)
Arrowhead Pharmaceuticals In Note 1/1 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Cogent Biosciences (COGT)
Genmab A/s Sponsored Ads (GMAB)
Brookdale Senior Living (BKD)
Vera Therapeutics Cl A (VERA)
Ionis Pharmaceuticals (IONS)

View all positions for Deerfield Management Company

Top funds holding Parabilis Medicines

RA Capital Management
FMR
Arch Venture Corp
venBio Partners
Nextech Invest
Cormorant Asset Management
Regeneron Pharmaceuticals
Farallon Capital Management
Jupiter Topco
Deerfield Management Company
General Atlantic
Soleus Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Jpmorgan Chase & Co

View all funds holding Parabilis Medicines